The correlation between the log 2 fold change of FPKM and the relative abundance determined by qRT-PCR was highly significant (R 2 = 0.92; p < 0.05) for the 16 genes selected ( Figure S2 ). 2.5.
Excerpts
This difference did not reach statistical significance (44 vs. 12%, p = 0.05, Table 1 ).
Among all NE formulations, the results of pH were quite significant (p < 0.05).
NLR ≥ 13.2 predicted in-hospital death with the sensitivity of 100% (95% CI 35.9–100%) and specificity of 92.6% (95% CI 88.8–95.4%), however, comparison of LoH among survivors did not reach statistical significance (P = 0.05).
marginally non-significantp = 0.05
The Wilcoxon test showed that the difference in FSS-7 score was marginally non-significant (p = 0.05, effect size = 0.37).
The effect of CgA was borderline significant (HR=0.76, 95% CI, 0.57-1, P =0.05) in the multivariate analysis ( 13 ).
borderline significancep = 0.05
Table 3 shows the age-and BMI-adjusted comparisons in bone turnover markers in both groups and revealed no significant differences with the exception of N-telopeptides of type I collagen (NTX) which were observed to be modestly higher in the normal BMD group than the low BMD group at borderline significance ( p = 0.05).
A p value < 0.01 (**) shows an extremely significant relationship while 0.01 < p < 0.05 (*) represents a significant relationship.
of borderline significanceP = 0.05
On analysis of nicotine infusions, although no main effect of treatment was recorded, a treatment by day interaction of borderline significance was noted (F16,152 = 1.7, P = 0.05) reflecting a treatment effect on infusions related to the test day.
in-person) was associated with a marginally significant reduction in breastfeeding initiation (B = −0.04, p = 0.05), with the confidence interval close to zero ([−0.08, −0.001]), suggesting a slight effect of telemedicine on lowering initiation rates.
The interaction between the three factors was also highly significant ( p < 0.05).
The CP content of the LAB group, CE group and LAB + CE group was increased by 17.41%, 12.02%, and 20.49%, respectively, compared to that of the CON group, and no difference was noted for the CP on the 2-way interaction of LAB × CE.The NDFom content in the LAB treatment group was not significantly different compared to the CON group( p > 0.05), and both the CE and LAB + CE groups showed a decreasing trend in DNFom content compared with the CON group, with decreases of 16.41% and 18.74%, respectively ( p < 0.05).
The 11 men who had erectile and ejaculatory dysfunction as a plausible escitalopram side-effect had lower mean testosterone (13.8 ± 4.7 nM) and estradiol (0.084 ± 0.023 nM) than the men without the side-effects (19.6 ± 8.7 nM and 0.110 ± 0.034 nM), which was borderline significant for testosterone (Hedges' g = 0.81, t (18.9) = 2.1, p = 0.050) and significant for estradiol using Welch's tests (Hedges' g = 0.86, t (20.9) = 2.2, p = 0.039).
borderline non-significantp = 0.050
In this population of patients undergoing mitral valve repair, Streptococcus was the most frequent pathogen (31.3%; p = 0.050, borderline non-significant), in contrast to Staphylococcus aureus , which was the most frequent pathogen in patients who underwent mitral valve replacement.
Prevalence of diseases A total of 3,493 chronic diseases were recorded in the population, corresponding to 4.6 diseases per LLI (4.8 in men and 4.5 in women, p < 0.05); there was a decreasing trend with age, from 4.7 in those under 98 vs. 3.3 in those over 100 ( p < 0.05).
Horizontally, SBD showed an increasing trend from the eastern to western sections ( P < 0.05) (Fig. 2 ).
Significant intergroup differences were observed in maternal age, paternal age, maternal BMI, and serum triglyceride levels, which showed an increasing trend with higher FPG levels (p < 0.05).
P < .01 was considered as having a highly significant difference, while P < .05 was regarded as having a significant difference.
Elevated WBC counts showed marginal significance (OR: 1.5; p=0.05), while serum amylase was not a significant predictor.
We first regress Y trc against c 1 , ⋯ , c K jointly and select the covariates with nominally significant coefficients ( p < 0.05).
BCSME is highly significant (P < 0.05) and the value of coefficient is positive.
The effect of condition was only marginally significant, F (4, 2817.63) = 2.33, p = 0.05, with none of the comparisons between conditions being significant, all p s > 0.10.
The odds ratio showed an increasing trend with longer follow-up periods (OR = 1.70; 95% CI 1.36–2.13; p ≤ 0.05 at ≤1 month, OR = 1.86; 95% CI 1.50–2.32; p ≤ 0.05 at ≤3 months, OR = 2.29; 95% CI 1.90–2.75; p ≤ 0.05 at ≤4 months, OR = 2.40; 95% CI 1.99–2.91; p ≤ 0.05 at ≤6 months, OR = 2.50; 95% CI 2.11–2.97; p ≤ 0.05 at ≤1 year).
A similar B-cell (CD20) and fibroblast (CD90) content was present in all tissues tested ( Figure 4B e,f), while a decreasing trend for T cells (CD3) could be detected in the adalimumab scFv-Fc ( p < 0.05 and p = 0.05) and A7/adalimumab ( p = 0.1 and p = 0.05) treatment groups compared to control and E2/adalimumab ( Figure 4B c).
The marginally significant interaction effect between education and severity, β = 0.57, t (1171) = 1.95, p = 0.05, was also tested.